|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
41,458
481.10
US$2,767,140
|
41,458
|
481.10
|
US$2,767,140
|
|
|
2026-06-08 |
2026-06-04 |
S
Sale
|
Principal Accounting Officer
Officer
|
40,050
-13.9%
455.75
US$1,719,646
|
40,050
-13.9%
|
455.75
|
US$1,719,646
|
|
|
2026-06-08 |
2026-06-04 |
S
Sale
|
Principal Accounting Officer
Officer
|
866
+33.9%
154.42
US$1,175,924
|
866
+33.9%
|
154.42
|
US$1,175,924
|
|
|
2026-06-04 |
2026-06-04 |
PrS
Proposed sale
|
Officer
Officer
|
2,639
100.00
US$263,900
|
2,639
|
100.00
|
US$263,900
|
|
|
2026-05-28 |
2026-05-26 |
S
Sale
|
Principal Accounting Officer
Officer
|
2,051
-8.8%
97.35
US$199,665
|
2,051
-8.8%
|
97.35
|
US$199,665
|
|
|
2026-05-26 |
2026-05-26 |
PrS
Proposed sale
|
Officer
Officer
|
2,051
97.35
US$199,665
|
2,051
|
97.35
|
US$199,665
|
|
|
2026-05-21 |
2026-05-19 |
S
Sale
|
Non-Executive Director
|
15,000
-38.7%
94.93
US$1,423,950
|
15,000
-38.7%
|
94.93
|
US$1,423,950
|
|
|
2026-05-21 |
2026-05-19 |
S
Sale
|
Non-Executive Director
|
15,000
-38.7%
94.93
US$1,423,950
|
15,000
-38.7%
|
94.93
|
US$1,423,950
|
|
|
2026-05-19 |
2026-05-19 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
15,000
94.93
US$1,424,006
|
15,000
|
94.93
|
US$1,424,006
|
|
|
2026-04-21 |
2026-04-17 |
S
Sale
|
President, Global Head of R&D
Officer
|
18,667
-6.6%
96.50
US$1,801,366
|
18,667
-6.6%
|
96.50
|
US$1,801,366
|
|
|
2026-04-17 |
2026-04-17 |
PrS
Proposed sale
|
Officer
Officer
|
18,667
96.50
US$1,801,326
|
18,667
|
96.50
|
US$1,801,326
|
|
|
2026-03-19 |
2026-03-17 |
S
Sale
|
President, R&D
Officer
|
18,667
-7.4%
94.24
US$1,759,178
|
18,667
-7.4%
|
94.24
|
US$1,759,178
|
|
|
2026-03-17 |
2026-03-17 |
PrS
Proposed sale
|
Officer
Officer
|
18,667
94.24
US$1,759,102
|
18,667
|
94.24
|
US$1,759,102
|
|
|
2026-02-23 |
2026-02-19 |
S
Sale
|
President, R&D
Officer
|
18,668
-7.4%
100.91
US$1,883,788
|
18,668
-7.4%
|
100.91
|
US$1,883,788
|
|
|
2026-02-19 |
2026-02-19 |
PrS
Proposed sale
|
Officer
Officer
|
18,668
100.91
US$1,883,797
|
18,668
|
100.91
|
US$1,883,797
|
|
|
2026-02-09 |
2026-02-09 |
PrS
Proposed sale
|
Officer
Officer
|
12,743
109.00
US$1,388,987
|
12,743
|
109.00
|
US$1,388,987
|
|
|
2026-01-08 |
2026-01-07 |
S
Sale
|
EVP, Head of US Oncology
Officer
|
10,856
-14.1%
109.07
US$1,184,064
|
10,856
-14.1%
|
109.07
|
US$1,184,064
|
|
|
2026-01-07 |
2026-01-07 |
PrS
Proposed sale
|
Officer
Officer
|
10,856
109.07
US$1,184,051
|
10,856
|
109.07
|
US$1,184,051
|
|
|
2026-01-06 |
2026-01-06 |
PrS
Proposed sale
|
Officer
Officer
|
95,811
104.35
US$9,998,256
|
95,811
|
104.35
|
US$9,998,256
|
|
|
2026-01-07 |
2026-01-05 |
S
Sale
|
EVP & Chief Medical Officer
Officer
|
15,634
-31.4%
101.70
US$1,589,978
|
15,634
-31.4%
|
101.70
|
US$1,589,978
|
|
|
2026-01-05 |
2026-01-05 |
PrS
Proposed sale
|
Officer
Officer
|
16,437
102.81
US$1,689,888
|
16,437
|
102.81
|
US$1,689,888
|
|
|
2026-01-05 |
2026-01-05 |
PrS
Proposed sale
|
Officer
Officer
|
15,634
101.70
US$1,589,995
|
15,634
|
101.70
|
US$1,589,995
|
|
|
2025-12-22 |
2025-12-19 |
S
Sale
|
Principal Accounting Officer
Officer
|
2,774
-10.8%
100.00
US$277,400
|
2,774
-10.8%
|
100.00
|
US$277,400
|
|
|
2025-12-19 |
2025-12-19 |
PrS
Proposed sale
|
Officer
Officer
|
2,774
100.00
US$277,400
|
2,774
|
100.00
|
US$277,400
|
|
|
2025-12-19 |
2025-12-19 |
PrS
Proposed sale
|
Officer
Officer
|
52,941
101.73
US$5,385,677
|
52,941
|
101.73
|
US$5,385,677
|
|
|
2025-12-22 |
2025-12-18 |
S
Sale
|
Principal Accounting Officer
Officer
|
600
-2.5%
98.25
US$58,950
|
600
-2.5%
|
98.25
|
US$58,950
|
|
|
2025-12-18 |
2025-12-18 |
PrS
Proposed sale
|
Officer
Officer
|
600
98.25
US$58,950
|
600
|
98.25
|
US$58,950
|
|
|
2025-12-18 |
2025-12-17 |
S
Sale
|
EVP, Head of Tech. Operations
Officer
|
4,323
-13.6%
97.26
US$420,455
|
4,323
-13.6%
|
97.26
|
US$420,455
|
|
|
2025-12-17 |
2025-12-17 |
PrS
Proposed sale
|
Officer
Officer
|
4,323
97.26
US$420,455
|
4,323
|
97.26
|
US$420,455
|
|
|
2025-12-18 |
2025-12-16 |
S
Sale
|
EVP, Head of Tech. Operations
Officer
|
53,175
-62.6%
97.29
US$5,173,396
|
53,175
-62.6%
|
97.29
|
US$5,173,396
|
|
|
2025-12-18 |
2025-12-16 |
S
Sale
|
EVP, Head of Tech. Operations
Officer
|
833
-1.0%
97.42
US$81,151
|
833
-1.0%
|
97.42
|
US$81,151
|
|
|
2025-12-16 |
2025-12-16 |
PrS
Proposed sale
|
Officer
Officer
|
13,388
98.39
US$1,317,245
|
13,388
|
98.39
|
US$1,317,245
|
|
|
2025-12-16 |
2025-12-16 |
PrS
Proposed sale
|
Officer
Officer
|
54,008
97.29
US$5,254,458
|
54,008
|
97.29
|
US$5,254,458
|
|
|
2025-12-15 |
2025-12-15 |
PrS
Proposed sale
|
Officer
Officer
|
187,690
97.00
US$18,205,930
|
187,690
|
97.00
|
US$18,205,930
|
|
|
2025-12-12 |
2025-12-11 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
255
-0.4%
94.94
US$24,210
|
255
-0.4%
|
94.94
|
US$24,210
|
|
|
2025-12-11 |
2025-12-11 |
PrS
Proposed sale
|
Officer
Officer
|
255
94.94
US$24,210
|
255
|
94.94
|
US$24,210
|
|
|
2025-12-12 |
2025-12-10 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
5,553
-8.4%
95.58
US$530,756
|
5,553
-8.4%
|
95.58
|
US$530,756
|
|
|
2025-12-10 |
2025-12-10 |
PrS
Proposed sale
|
Officer
Officer
|
5,553
95.58
US$530,756
|
5,553
|
95.58
|
US$530,756
|
|
|
2025-12-10 |
2025-12-10 |
PrS
Proposed sale
|
Officer
Officer
|
23,104
95.51
US$2,206,695
|
23,104
|
95.51
|
US$2,206,695
|
|
|
2025-12-03 |
2025-12-02 |
S
Sale
|
EVP & Chief Medical Officer
Officer
|
20,105
-24.2%
102.51
US$2,060,964
|
20,105
-24.2%
|
102.51
|
US$2,060,964
|
|
|
2025-12-02 |
2025-12-02 |
PrS
Proposed sale
|
Officer
Officer
|
20,105
102.51
US$2,060,978
|
20,105
|
102.51
|
US$2,060,978
|
|
|
2025-12-03 |
2025-12-01 |
S
Sale
|
EVP & Chief Medical Officer
Officer
|
2,559
-2.5%
102.96
US$263,475
|
2,559
-2.5%
|
102.96
|
US$263,475
|
|
|
2025-12-01 |
2025-12-01 |
PrS
Proposed sale
|
Officer
Officer
|
2,559
102.96
US$263,482
|
2,559
|
102.96
|
US$263,482
|
|
|
2025-11-25 |
2025-11-24 |
S
Sale
|
Principal Accounting Officer
Officer
|
600
-2.5%
103.00
US$61,800
|
600
-2.5%
|
103.00
|
US$61,800
|
|
|
2025-11-24 |
2025-11-24 |
PrS
Proposed sale
|
Officer
Officer
|
600
103.00
US$61,800
|
600
|
103.00
|
US$61,800
|
|
|
2025-11-25 |
2025-11-21 |
S
Sale
|
Principal Accounting Officer
Officer
|
169
-0.7%
102.00
US$17,238
|
169
-0.7%
|
102.00
|
US$17,238
|
|
|
2025-11-21 |
2025-11-21 |
PrS
Proposed sale
|
Officer
Officer
|
169
102.00
US$17,238
|
169
|
102.00
|
US$17,238
|
|
|
2025-11-19 |
2025-11-17 |
S
Sale
|
EVP & General Counsel
Officer
|
278
-1.0%
104.36
US$29,012
|
278
-1.0%
|
104.36
|
US$29,012
|
|
|
2025-11-17 |
2025-11-17 |
PrS
Proposed sale
|
Officer
Officer
|
278
104.36
US$29,012
|
278
|
104.36
|
US$29,012
|
|
|
2025-11-12 |
2025-11-12 |
PrS
Proposed sale
|
Officer
Officer
|
7,442
109.00
US$811,178
|
7,442
|
109.00
|
US$811,178
|
|
|
2025-11-12 |
2025-11-10 |
S
Sale
|
Non-Executive Director
|
187,500
-36.3%
105.46
US$19,773,750
|
187,500
-36.3%
|
105.46
|
US$19,773,750
|
|
|
2025-11-10 |
2025-11-10 |
PrS
Proposed sale
|
Officer; Director
Executive Director
|
187,500
105.46
US$19,773,454
|
187,500
|
105.46
|
US$19,773,454
|
|
|
2025-11-07 |
2025-11-05 |
S
Sale
|
EVP & Chief Medical Officer
Officer
|
5,233
-4.8%
102.20
US$534,813
|
5,233
-4.8%
|
102.20
|
US$534,813
|
|
|
2025-11-05 |
2025-11-05 |
PrS
Proposed sale
|
Officer
Officer
|
5,233
102.20
US$534,813
|
5,233
|
102.20
|
US$534,813
|
|
|
2025-11-06 |
2025-11-04 |
S
Sale
|
EVP & General Counsel
Officer
|
598
-2.2%
101.36
US$60,613
|
598
-2.2%
|
101.36
|
US$60,613
|
|
|
2025-11-04 |
2025-11-04 |
PrS
Proposed sale
|
Officer
Officer
|
598
101.36
US$60,613
|
598
|
101.36
|
US$60,613
|
|
|
2025-11-05 |
2025-11-03 |
S
Sale
|
EVP, Head of Incyte Intl
Officer
|
3,074
-9.5%
94.02
US$289,017
|
3,074
-9.5%
|
94.02
|
US$289,017
|
|
|
2025-11-03 |
2025-11-03 |
PrS
Proposed sale
|
Officer
Officer
|
3,074
94.02
US$289,017
|
3,074
|
94.02
|
US$289,017
|
|
|
2025-11-03 |
2025-11-03 |
PrS
Proposed sale
|
Officer
Officer
|
22,113
97.74
US$2,161,367
|
22,113
|
97.74
|
US$2,161,367
|
|
|
2025-10-30 |
2025-10-30 |
PrS
Proposed sale
|
Officer
Officer
|
14,986
94.00
US$1,408,684
|
14,986
|
94.00
|
US$1,408,684
|
|
|
2025-10-27 |
2025-10-27 |
PrS
Proposed sale
|
Officer
Officer
|
33,452
91.73
US$3,068,539
|
33,452
|
91.73
|
US$3,068,539
|
|
|
2025-10-16 |
2025-10-16 |
PrS
Proposed sale
|
Officer
Officer
|
18,495
92.38
US$1,708,609
|
18,495
|
92.38
|
US$1,708,609
|
|
|
2025-10-17 |
2025-10-15 |
S
Sale
|
EVP & General Counsel
Officer
|
277
-1.0%
85.13
US$23,581
|
277
-1.0%
|
85.13
|
US$23,581
|
|
|
2025-10-15 |
2025-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
277
85.13
US$23,581
|
277
|
85.13
|
US$23,581
|
|
|
2025-10-06 |
2025-10-03 |
S
Sale
|
EVP & General Counsel
Officer
|
3,501
-11.6%
85.54
US$299,476
|
3,501
-11.6%
|
85.54
|
US$299,476
|
|
|
2025-10-03 |
2025-10-03 |
PrS
Proposed sale
|
Officer
Officer
|
3,501
85.54
US$299,464
|
3,501
|
85.54
|
US$299,464
|
|
|
2025-10-06 |
2025-10-02 |
S
Sale
|
EVP & General Counsel
Officer
|
599
-1.8%
87.65
US$52,502
|
599
-1.8%
|
87.65
|
US$52,502
|
|
|
2025-10-02 |
2025-10-02 |
PrS
Proposed sale
|
Officer
Officer
|
599
87.65
US$52,502
|
599
|
87.65
|
US$52,502
|
|
|
2025-09-18 |
2025-09-18 |
PrS
Proposed sale
|
Officer
Officer
|
17,447
85.26
US$1,487,531
|
17,447
|
85.26
|
US$1,487,531
|
|
|
2025-09-18 |
2025-09-16 |
S
Sale
|
EVP & General Counsel
Officer
|
278
-0.8%
83.15
US$23,116
|
278
-0.8%
|
83.15
|
US$23,116
|
|
|
2025-09-16 |
2025-09-16 |
PrS
Proposed sale
|
Officer
Officer
|
278
83.15
US$23,116
|
278
|
83.15
|
US$23,116
|
|
|
2025-09-04 |
2025-09-02 |
S
Sale
|
EVP & General Counsel
Officer
|
598
-1.8%
84.97
US$50,812
|
598
-1.8%
|
84.97
|
US$50,812
|
|
|
2025-09-02 |
2025-09-02 |
PrS
Proposed sale
|
Officer
Officer
|
598
84.97
US$50,812
|
598
|
84.97
|
US$50,812
|
|
|
2025-08-19 |
2025-08-15 |
S
Sale
|
EVP & General Counsel
Officer
|
277
-0.8%
86.81
US$24,046
|
277
-0.8%
|
86.81
|
US$24,046
|
|
|
2025-08-15 |
2025-08-15 |
PrS
Proposed sale
|
Officer
Officer
|
277
86.81
US$24,046
|
277
|
86.81
|
US$24,046
|
|